GH Research (GHRS) Payables (2021 - 2025)
GH Research (GHRS) recorded quarterly Payables of $3.8 million in Q4 2025, down 1.67% quarter-over-quarter from $3.8 million in Q3 2025, and up 0.86% on a YoY basis from $3.7 million in Q4 2024.
GH Research (GHRS) Payables (2021 - 2025) Analysis & Trends
GH Research's Payables history runs 5 years deep, the most recent figure standing at $3.8 million for Q4 2025.
- In Q4 2025, Payables rose 0.86% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (up 0.86% YoY), while the FY2025 annual figure was $3.8 million, up 0.86% from the prior year.
- Payables was $3.8 million for Q4 2025 at GH Research, down from $3.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $4.8 million in Q1 2025 to a low of $399000.0 in Q4 2021.
- Historically, Payables has averaged $2.7 million across 5 years, with a median of $2.9 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Payables soared 368.17% in 2022, then decreased 11.68% in 2024.
- A 5-year view of Payables shows it stood at $399000.0 in 2021, then jumped by 368.17% to $1.9 million in 2022, then jumped by 86.83% to $3.5 million in 2023, then increased by 7.19% to $3.7 million in 2024, then advanced by 0.86% to $3.8 million in 2025.
- The last three Payables figures came in at $3.8 million (Q4 2025), $3.8 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 3.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 3.74 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 3.55 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 399,000.00 |
| Sep 30, 2021 | 1.21 Mn |